Quick Takeaways
- ARK Investment Management LLC filed SCHEDULE 13G/A for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX).
- Disclosed ownership: 8.5%.
- Date of event: 31 Dec 2024.
ARK Investment Management LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)
- Filing Manager
- ARK Investment Management LLC
- Reporting Manager
- ARK Investment Management LLC
- Symbol
- RXRX
- Shares outstanding
- 381,893,707 shares
- Disclosed Ownership
- 32,346,397 shares
- Ownership
- 8.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 11:23:34 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 03 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ARK Investment Management LLC disclosed 8.5% ownership in Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 11:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 8.5% | 32,346,397 | 30,689,945 | 552,872 | /s/ Kellen Carter | Kellen Carter, Chief Compliance Officer |